WALTHAM, Mass.--(BUSINESS WIRE)--Entasis Therapeutics, a company leveraging its expertise and a unique pathogen-targeted approach to develop and advance novel antibacterials, today announced the appointment of Robin David Isaacs, M.D., as Chief Medical Officer. Dr. Isaacs has extensive experience as a pharmaceutical executive in the development and launch of vaccine and infectious disease products.
Help employers find you! Check out all the jobs and post your resume.
